These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4987582)

  • 21. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
    Silbergeld EK; Hruska RE
    Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1983 Jun; 22(6):669-76. PubMed ID: 6888664
    [No Abstract]   [Full Text] [Related]  

  • 23. Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.
    Green JP; Johnson CL; Weinstein H; Maayani S
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5697-701. PubMed ID: 23536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of central monoaminergic neurons to lisuride: comparison with LSD.
    Rogawski MA; Aghajanian GK
    Life Sci; 1979 Apr; 24(14):1289-97. PubMed ID: 470543
    [No Abstract]   [Full Text] [Related]  

  • 26. Emetic activity of reduced lysergamides.
    Johnson FN; Ary IE; Teiger DG; Kassel RJ
    J Med Chem; 1973 May; 16(5):532-7. PubMed ID: 4718471
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of lysergic acid diethylamide (LSD-25) upon conditioning and sweating].
    Sivadjian J
    Therapie; 1970; 25(4):813-21. PubMed ID: 5458924
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
    Kehr W; Speckenbach W
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
    [No Abstract]   [Full Text] [Related]  

  • 29. Action of lysergide, ephedrine, and nimergoline on brain metabolizing activity.
    Benzi G; Manzo L; De Bernardi M; Ferrara A; Sanguinetti L; Arrigoni E; Berté F
    J Pharm Sci; 1971 Sep; 60(9):1320-4. PubMed ID: 5567577
    [No Abstract]   [Full Text] [Related]  

  • 30. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.
    Adams LM; Geyer MA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):461-8. PubMed ID: 4048241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
    Pieri M; Schaffner R; Pieri L; Da Prada M; Haefely W
    Life Sci; 1978 May; 22(18):1615-22. PubMed ID: 307642
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
    Commissaris RL; Rech RH
    Psychopharmacology (Berl); 1982; 76(3):282-5. PubMed ID: 6808551
    [No Abstract]   [Full Text] [Related]  

  • 34. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anxiety and flight reactions in experimental cerebellar lesions].
    LEDINSKA N; MASIN Z
    Cesk Psychiatr; 1961 Dec; 57():389-93. PubMed ID: 14463440
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of noradrenaline release by lysergic acid diethylamide.
    Hughes J
    Br J Pharmacol; 1973 Dec; 49(4):706-8. PubMed ID: 4788042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
    Bürki HR; Asper H; Ruch W; Züger PE
    Psychopharmacology (Berl); 1978 May; 57(3):227-37. PubMed ID: 97702
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of drugs on visually controlled avoidance behavior in rhesus monkeys: a psychophysical analysis.
    Brown H; Bass WC
    Psychopharmacologia; 1967; 11(2):143-53. PubMed ID: 4968293
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct action of D-lysergic acid diethylamide on dispersed mucosal cells from guinea pig stomach.
    Batzri S; Dyer J
    Biochem Pharmacol; 1982 Aug; 31(16):2676-9. PubMed ID: 6291541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.